Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Alligator Bioscience
Alligator Bioscience
Activities:
Regulatory
Research & Development
X
LinkedIn
Trending Articles
Rousselot
Rousselot is the global leader* of collagen-based solutions for the food, health and nutrition, biomedical and pharmaceutical sectors. Working in partnership with our global...
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Donaldson's Isolere Bio launches IsoTag reagent for optimal AAV purification
The IsoTag AAV reagent can purify adeno associated viruses for research purposes, achieving up to an 85% in yield
Novo Nordisk's haemophilia A/B drug Alhemo gets positive opinion from the EMA
The subcutaneous, self-administering prophylactic can allow a patient to produce thrombin, a clotting agent, even in the presence of inhibitors
groninger showcases filling and closing solutions for OTC pharma at Pack Expo
Discover the flexcare 101 and flexfill machines designed for enhanced efficiency and flexibility in pharmaceutical production
Upcoming event
Lab Innovations
30-31 October 2024 | Exhibition | Birmingham, UK
See all
Related Content
Research & Development
Aptevo and Alligator Bioscience develop immunotherapy candidate
Aptevo Therapeutics and Alligator Bioscience begin investigational new drug development to investigate the bispecific immunotherapy candidate ALG.APV-527
Ingredients
Cobra Biologics and Alligator Bioscience extend drug development partnership
Project will deliver second cell line to manufacture immuno-oncology antibody ADC-1015 following ADC-1013 success
Research & Development
J&J announces immuno-oncology collaboration with Alligator Bioscience
Alligator will complete the current Phase I study and Janssen will be responsible for all subsequent product development
Ingredients
Alligator Bioscience benefits from Cobra’s maxXpress platform
Cobra developed the cell line to express agonistic CD40 antibodies for an immuno-oncology application using its maxXpress platform
Manufacturing
Cobra to produce monoclonal antibody products for Alligator
Will provide cell line development, scale-up, GMP supplies and stability studies
Subscribe now